Alnylam Pharmaceuticals is a startup based in All, most recent round IPO, 2 tracked investors.
Alnylam Pharmaceuticals is a startup based in All. Its most recent tracked round is IPO. Brouky records 2 investors associated with the company.
Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.